VPAResearch: Market Research Reports

Publications found: 64,029

Sort by:

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 &nb...

February 2023 50 pages

Microscopic Polyangiitis (MPA) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Microscopic Polyangiitis (MPA) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Microsco...

February 2023 40 pages

Middle East Respiratory Syndrome (MERS) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Middle East Respiratory Syndrome (MERS) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the...

February 2023 200 pages

Mild Cognitive Impairment Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Mild Cognitive Impairment Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Mild Cognitiv...

February 2023 170 pages

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For e...

February 2023 90 pages

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For...

February 2023 80 pages

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 202...

February 2023 90 pages

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development...

February 2023 140 pages

Mumps Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Mumps Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Mumps pipeline candidate, details...

February 2023 40 pages

Myasthenia Gravis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Myasthenia Gravis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Myasthenia Gravis pip...

February 2023 190 pages

Myocardial Fibrosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Myocardial Fibrosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Myocardial Fibrosis...

February 2023 60 pages

Myocardial Ischemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Myocardial Ischemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Myocardial Ischemia...

February 2023 80 pages

Myocarditis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Myocarditis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Myocarditis pipeline candid...

February 2023 40 pages

Narcolepsy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Narcolepsy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Narcolepsy pipeline candidat...

February 2023 110 pages

Nasal Polyps (Nasal Polyposis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Nasal Polyps (Nasal Polyposis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Nasal Po...

February 2023 50 pages

Nasopharyngitis (Common Cold) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Nasopharyngitis (Common Cold) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Nasophary...

February 2023 40 pages

Neisseria Meningitidis Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Neisseria Meningitidis Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Neiss...

February 2023 110 pages

Nephrotic Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Nephrotic Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Nephrotic Syndrome p...

February 2023 40 pages

Neurofibromatoses Type I (Von Recklinghausen’s Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Neurofibromatoses Type I (Von Recklinghausen’s Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023....

February 2023 80 pages

Neurofibromatoses Type II Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Neurofibromatoses Type II Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Neurofibromat...

February 2023 50 pages

Neuromyelitis Optica (Devic’s Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Neuromyelitis Optica (Devic’s Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the...

February 2023 170 pages

Neutropenia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Neutropenia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Neutropenia pipeline candid...

February 2023 130 pages

Nocturia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Nocturia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Nocturia pipeline candidate, d...

February 2023 40 pages

Ocular Hypertension Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Ocular Hypertension Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Ocular Hypertension...

February 2023 160 pages

Oligodendroglioma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Oligodendroglioma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Oligodendroglioma pip...

February 2023 100 pages

Onychomycosis (Tinea Unguium) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Onychomycosis (Tinea Unguium) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Onychomyc...

February 2023 100 pages

Opioid-Induced Constipation (OIC) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Opioid-Induced Constipation (OIC) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Opioi...

February 2023 40 pages

Optic Neuritis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Optic Neuritis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Optic Neuritis pipeline...

February 2023 60 pages

Optic Neuropathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Optic Neuropathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Optic Neuropathy pipel...

February 2023 40 pages

Oral Mucositis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Oral Mucositis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Oral Mucositis pipeline...

February 2023 50 pages

Organophosphate and Carbamate Poisoning Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Organophosphate and Carbamate Poisoning Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the...

February 2023 40 pages

Ornithine-Transcarbamylase Deficiency Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Ornithine-Transcarbamylase Deficiency Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the O...

February 2023 60 pages

Osteogenesis Imperfecta Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Osteogenesis Imperfecta Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Osteogenesis Im...

February 2023 60 pages

Osteomyelitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Osteomyelitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Osteomyelitis pipeline ca...

February 2023 40 pages

Osteonecrosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Osteonecrosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Osteonecrosis pipeline ca...

February 2023 40 pages

Otitis Media Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Otitis Media Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Otitis Media pipeline cand...

February 2023 90 pages

Overactive Bladder Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Overactive Bladder Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Overactive Bladder p...

February 2023 120 pages

Pancreatitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Pancreatitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Pancreatitis pipeline cand...

February 2023 130 pages

Paroxysmal Nocturnal Hemoglobinuria Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Paroxysmal Nocturnal Hemoglobinuria Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Par...

February 2023 140 pages

Peanut Allergy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Peanut Allergy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Peanut Allergy pipeline...

February 2023 130 pages

Peptic Ulcers Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Peptic Ulcers Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Peptic Ulcers pipeline ca...

February 2023 110 pages

Periodontitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Periodontitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Periodontitis pipeline ca...

February 2023 60 pages

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1&nbs...

February 2023 190 pages

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For e...

February 2023 140 pages

Peritonitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Peritonitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Peritonitis pipeline candid...

February 2023 50 pages

Pertussis (Whooping Cough) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Pertussis (Whooping Cough) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Pertussis (W...

February 2023 130 pages

Phenylketonuria (PKU) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Phenylketonuria (PKU) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Phenylketonuria (...

February 2023 110 pages

Pheochromocytoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Pheochromocytoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Pheochromocytoma pipel...

February 2023 60 pages

Pigmented Villonodular Synovitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Pigmented Villonodular Synovitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Pigmen...

February 2023 40 pages

Pituitary ACTH Hypersecretion (Cushing Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 1,890.00

Pituitary ACTH Hypersecretion (Cushing Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For eac...

February 2023 40 pages

Filters

Clear all